SMT201900220T1 - Formulazione di nicotina - Google Patents

Formulazione di nicotina

Info

Publication number
SMT201900220T1
SMT201900220T1 SM20190220T SMT201900220T SMT201900220T1 SM T201900220 T1 SMT201900220 T1 SM T201900220T1 SM 20190220 T SM20190220 T SM 20190220T SM T201900220 T SMT201900220 T SM T201900220T SM T201900220 T1 SMT201900220 T1 SM T201900220T1
Authority
SM
San Marino
Prior art keywords
nicotine formulation
nicotine
formulation
Prior art date
Application number
SM20190220T
Other languages
English (en)
Italian (it)
Inventor
Fredrik Hübinette
Original Assignee
Nicoccino Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoccino Ab filed Critical Nicoccino Ab
Publication of SMT201900220T1 publication Critical patent/SMT201900220T1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SM20190220T 2012-03-27 2013-03-15 Formulazione di nicotina SMT201900220T1 (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261615997P 2012-03-27 2012-03-27
EP12161483 2012-03-27
EP13712730.4A EP2830589B1 (en) 2012-03-27 2013-03-15 Nicotine formulation
PCT/EP2013/055456 WO2013143891A1 (en) 2012-03-27 2013-03-15 Nicotine formulation

Publications (1)

Publication Number Publication Date
SMT201900220T1 true SMT201900220T1 (it) 2019-07-11

Family

ID=49258262

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20190220T SMT201900220T1 (it) 2012-03-27 2013-03-15 Formulazione di nicotina

Country Status (21)

Country Link
US (1) US20150096572A1 (enExample)
EP (1) EP2830589B1 (enExample)
JP (2) JP6412492B2 (enExample)
KR (1) KR102038342B1 (enExample)
CN (1) CN104411297B (enExample)
AU (1) AU2013242200B2 (enExample)
BR (1) BR112014023823B1 (enExample)
CA (1) CA2868445C (enExample)
IN (1) IN2014DN08879A (enExample)
MX (1) MX362918B (enExample)
MY (1) MY183216A (enExample)
NZ (1) NZ626974A (enExample)
PL (1) PL2830589T3 (enExample)
RS (1) RS58677B1 (enExample)
RU (1) RU2625836C2 (enExample)
SG (1) SG11201405958RA (enExample)
SI (1) SI2830589T1 (enExample)
SM (1) SMT201900220T1 (enExample)
UA (1) UA116440C2 (enExample)
WO (1) WO2013143891A1 (enExample)
ZA (1) ZA201407677B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659696B (zh) * 2014-07-08 2021-08-20 费尔廷制药公司 包含两个隔室的经口递送系统
JP2020500220A (ja) 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
US20200085806A1 (en) * 2016-12-20 2020-03-19 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
GB201808462D0 (en) * 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
BR112021009438A2 (pt) * 2018-12-28 2021-08-17 Philip Morris Products S.A. formulação de nicotina compreendendo sal metálico
MX2021007624A (es) * 2018-12-31 2021-08-11 Philip Morris Products Sa Formulacion de nicotina liquida.
GB201912505D0 (en) * 2019-08-30 2019-10-16 Klaria Pharma Holding Ab Pharmaceutical formulation
SE544672C2 (en) 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
GB0508306D0 (en) * 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
MY185300A (en) * 2007-10-11 2021-04-30 Philip Morris Products Sa Smokeless tobacco product
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
SI2405942T1 (en) * 2009-03-13 2018-04-30 Excellent Tech Products I Sverige Ab Oral delivery product

Also Published As

Publication number Publication date
BR112014023823B1 (pt) 2022-04-26
CA2868445A1 (en) 2013-10-03
MY183216A (en) 2021-02-18
MX362918B (es) 2019-02-26
PL2830589T3 (pl) 2019-07-31
JP6412492B2 (ja) 2018-10-24
ZA201407677B (en) 2016-05-25
EP2830589A1 (en) 2015-02-04
AU2013242200A1 (en) 2014-10-16
JP2017226686A (ja) 2017-12-28
WO2013143891A1 (en) 2013-10-03
US20150096572A1 (en) 2015-04-09
RU2014143003A (ru) 2016-05-20
NZ626974A (en) 2016-09-30
RU2625836C2 (ru) 2017-07-19
SG11201405958RA (en) 2014-10-30
EP2830589B1 (en) 2019-02-13
MX2014010760A (es) 2015-03-20
AU2013242200B2 (en) 2017-03-02
RS58677B1 (sr) 2019-06-28
CA2868445C (en) 2020-01-28
KR102038342B1 (ko) 2019-10-30
IN2014DN08879A (enExample) 2015-05-22
KR20140140021A (ko) 2014-12-08
CN104411297B (zh) 2017-10-24
JP2015516948A (ja) 2015-06-18
BR112014023823A2 (enExample) 2017-06-20
CN104411297A (zh) 2015-03-11
SI2830589T1 (sl) 2019-06-28
UA116440C2 (uk) 2018-03-26
HK1205679A1 (en) 2015-12-24

Similar Documents

Publication Publication Date Title
ZA201502013B (en) Nicotine composition
PL3466282T3 (pl) Urządzenia generujące aerozol
SG11201406967XA (en) Tobacco substrate
PL2877155T3 (pl) Formulacje opioidowe
IL289157A (en) Opioid compounds
PL2900303T3 (pl) Inhalator
ZA201407677B (en) Nicotine formulation
ZA201306000B (en) Stable formulation
ZA201409020B (en) Pharmaceutical formulation
PL2856890T3 (pl) Papieros
EP2800474A4 (en) COFFEE FORMULATION
ZA201408114B (en) Oral formulation
AU345797S (en) Cigarette
AU345796S (en) Cigarette
PL2908859T3 (pl) Formulacje arypiprazolu
IL234771B (en) Nicotine formulation
GB201211247D0 (en) Improved formulation
GB201206178D0 (en) Formulations
AU345795S (en) Cigarette
AU345910S (en) Cigarette
GB201206124D0 (en) Match my fit
GB201210088D0 (en) Odontalgic preparation